EC Number   |
Application |
Reference |
|---|
    2.1.2.3 | diagnostics |
enzyme variants are used to predict methotrexate response in juvenile idiopathic arthritis, overview |
737222 |
| 2.1.2.3 | drug development |
the enzyme is an important drug target |
756701 |
| 2.1.2.3 | medicine |
- |
172161, 172163, 485750, 485757, 485758, 485759, 485760 |
| 2.1.2.3 | medicine |
animal model of systemic autoimmune disease |
485750 |
| 2.1.2.3 | medicine |
attractive anticancer target |
485755 |
| 2.1.2.3 | medicine |
potential target for antineoplastic chemotherapy |
658284, 659419 |
| 2.1.2.3 | medicine |
potential target for antineoplastic drug design |
659681 |
| 2.1.2.3 | medicine |
potential target for development of antineoplastic drugs |
485760 |
| 2.1.2.3 | medicine |
target for development of inhibitors with potential use as chemotherapeutic agents |
172161, 172163, 485754, 485756, 485757, 485758, 485759, 485760 |
